← Evidence map

ArticleScientific reports2021

Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease.

Kevin A Lidberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33633318